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Aim and clinical rationale for the study: Spontaneous intracerebral haemorrhage (sICH) is an
acute life-threatening injury and constitutes 10–15% of ﬁrst-ever stroke cases. The Surgical
Trials in Intracerebral Haematoma studies (STICH and STICH II) represent the two foremost
studies in the ﬁeld, however, with arguable shortcomings. To ﬁndmore accurate criteria, we
aimed to correlate the preoperative neurological and neuroimaging ﬁndingswith the clinical
outcome of operated patients.
Materials and methods: In this retrospective study, sICH patients were recruited from the
Central Denmark Region from 2010 to 2016. We evaluated the patients' medical records
regarding preoperative Glasgow Coma Scale (GCS) 6months and one year after surgery, focal
neurological defects, thrombolytic treatment, pupil status, and haemorrhage localization
visualized by neuroimaging. The patients' clinical outcome was assessed using the Glasgow
Outcome Scale (GOS).
Results: Based on logistic multiple linear analysis, age, basal ganglia haemorrhage andmass
effect had signiﬁcant effect on the mortality rate. Besides, age, basal ganglia haemorrhage,
intra ventricular haemorrhage and pupil difference had signiﬁcant correlation with good
outcome (GOS > 3).
Conclusions and clinical implications: Neurosurgical treatment of the sICH patients is indicated
only if age and potentially improved morbidity is carefully evaluated considering the STICH
and this study; otherwise, we will just increase the health care burden with a number of
extremely care-dependent patients.
© 2018 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.* Corresponding author at: Department of ClinicalMedicine, AarhusUniversityHospital, Building 10, 5thﬂoor, DK-8000Aarhus C, Denmark.
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is an acute life-threatening event with high mortality and
morbidity rates. The incidence rate is 12–20 cases per 100,000,
and despite a high level of treatment, the six-monthmortality
rate is 24%. Out of all treated patients, 50% survived to
dependency andnursery home. Only 26%of patients survive to
a favourable clinical outcome [1,2]. The decision between
conservative or surgical treatment is still controversial. Some
studies have reported a borderline lower 30-day mortality of
operated vs non-operated patients, but the overall morbidity
and mortality for the two groups does not differ signiﬁcantly
[3]. The Surgical Trials in Intracerebral Haematoma studies
(STICHandSTICH II) [1,3] represent the two foremost studies in
the ﬁeld. STICH was unable to show an overall beneﬁt of early
surgery compared to conservative treatment [4,5]. The impact
of the STICH studies on the policy of patient admission in
neurosurgery is also controversial, as some studies indicate
that the number of patient admissions and neurosurgical
evacuation have decreased [6]. However, other studies of
neurosurgical departments having implemented STICH as
principle guideline show that the rate of surgery is stable and
in-hospital ICHmortality decrease. Nevertheless, it is not clear
whether this is associated with longer-term mortality or
improved functional outcomes [7]. Therefore, further studies
and optimization of clinical criteria for surgical treatment of
sICH is still in high demand. Proper decisive classiﬁcation of
patients based on symptoms and para-clinical ﬁndings would
support decision-making.
Although it is the policy of our department to base sICH
treatment on the recent STICH I and II studies, the decision to
operate a patient with sICH is ultimately made by the
consultant on-call and is expert level III evidence at best. As
we had no local data to support our decisions, we set out to
analyze our surgical results, considering morbidity, mortality
and to identify subgroups. The aim of this study was to
correlate pre-operative neurological status and neuroimaging
ﬁndings with the clinical outcome of operated patients with
sICH in order to help determine more accurate criteria for
surgical intervention.
2. Materials and methodsTable 1 – Comparison between the outcome of sICH-
operations in Central Denmark Region and the STICH
study.
NK STICH 1
Mortality (6 mths) 18.3% 36%
GOS 1–3 74.65% 38%
GOS 4–5 25.35% 26% (Rankin 0–3)
Average hospitalization day 10.4 NSa
Additional procedure (EVD, shunt) 18% 16%
Nursing home (among GOS 1–3) 56.34% NSa
a NS, not stated.In a retrospective manner, we evaluated all themedical records
of all sICH patients in the Central Denmark Region who had
been primarily operated after sICH from 2010 to 2016. The
patient data was collected under a permission issued by the
Danish Ministry of Health. All patients were assigned to the
same neurosurgical department, and after treatment, all were
referred to theneuro rehabilitation centre in thesame region.All
patient medical records in the region, as well as the rest of
Denmark, are available in the national register system (E-
journal) which makes the informative follow-up possible.
Patient medical characteristics concerning pre-morbidity and
preoperative status such as gender, age, performance status
(based on WHO's classiﬁcation), thrombolytic treatment, initial
GCS, pupil status, and focal neurological deﬁcitswere registered.Own home or nursing home accommodation of patients
after discharge from the rehabilitation centre was used as
evidence of functional adequacy and registered. The outcome
of the surgery followed by rehabilitation was also enumerated
either as the 6-monthmortality rate or as the functional state,
based on Glasgow Outcome Scale (GOS) after a year [8]. A good
clinical outcome, equivalent to living self-reliantly, was
considered as GOS ≥ 4 [8]. Intracerebral haematoma charac-
teristics such as depth, volume, the involvement of basal
ganglia, the openness of basal cisterns, the existence of
intraventricular haemorrhage, and mass effect were also
investigated and evaluated by a CT-scan. All patients with
posterior fossa haemorrhage and secondary cause of bleeding
such as an aneurysm, vascular malformation, neoplasm, and
coagulopathy were excluded in line with the STICH studies.
Outcome is given in percentages, group differences were
analyzed by multiple linear regression tests, and p-values
≤0.05 was considered signiﬁcant.
3. ResultsMedical records from 153 patients were evaluated and 71 were
included for further analysis after assessing inclusion criteria
for spontaneous ICH.
The six-monthmortality rate for all the patients was 18.3%.
Results in comparison to the surgical results of the STICH 2
study are shown in Table 1. The median age of STICH subjects
was 63 years and in our study themedian age was also 63 (std.
dev. 13.5 yrs. range 23–85 yrs.). Only 6.1% of the treated
patients above 65 years survived to an independent life,
against 42.1% of patients below 65 years with a good outcome
after surgery (GOS 4–5). Table 2 illustrates GOS andmortality in
the different data sets.
Of all the patients who received surgical treatment, 74.6%
survived with GOS ≤ 3, while only 25.3% had shown improve-
ment and recovery with GOS ≥ 4, which indicates the ability to
live independently. About 40% of all treated patients were
admitted to a nursing home after treatment.
To sum up, two logistic multiple linear regression models
have been used on the data. One model focusing on the
relationship between the mortality rate and some variables
(called predictors), and another model focusing on the
relationship between the good outcome probability (GOS > 3)
and some predictors.
Table 2 – Mortality and GOS of subjects based on different predictors.
Death
(proportion)
GOS more than 3
(proportion)
Death
(number)
GOS more
than 3
(number)
No Yes No Yes No Yes No Yes
Gender F 76.5 23.5 73.5 26.5 26 8 25 9
M 86.5 13.5 75.7 24.3 32 5 28 9
Older than 65 No 94.7 5.3 57.9 42.1 36 2 22 16
Yes 66.7 33.3 93.9 6.1 22 11 31 2
Antithrombotic treatment No 85.7 14.3 67.4 32.7 42 7 33 16
Yes 72.7 27.3 90.9 9.1 16 6 20 2
GCS less than 8 No 80.0 20.0 71.1 28.9 36 9 32 13
Yes 84.6 15.4 80.8 19.2 22 4 21 5
Paresis No 78.6 21.4 50.0 50.0 11 3 7 7
Yes 82.5 17.5 80.7 19.3 47 10 46 11
Aphasia No 80.0 20.0 77.1 22.9 28 7 27 8
Yes 83.3 16.7 72.2 27.8 30 6 26 10
Pupil difference No 82.5 17.5 67.5 32.5 33 7 27 13
Yes 80.7 19.4 83.9 16.1 25 6 26 5
IVH No 90.9 9.1 60.6 39.4 30 3 20 13
Yes 73.7 26.3 86.8 13.2 28 10 33 5
Basal ganglia haemorrhage No 87.0 13.0 66.7 33.3 47 7 36 18
Yes 64.7 35.3 100.0 0.0 11 6 17 0
Mass effect No 94.1 5.9 82.4 17.7 16 1 14 3
Yes 77.8 22.2 72.2 27.8 42 12 39 15
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resulting in the best performing model, we used the stepwise
regression method.
The result of this method showed that mortality rate
depends on the age of the patient, and on whether the patient
has mass effect and/or basal ganglia haemorrhage (model-I).
Besides, the probability of a patient having a good outcome
(GOS > 3) depends on the age of the patient, and on whether
the patient has basal ganglia haemorrhage, IVH and/or pupil
difference (model-II).
The p-value from testing whether a model including
mortality rate versus all available predictive variables (called
full model) differs from a model including mortality rate
versus age, mass effect and basal ganglia haemorrhage equals
0.5417. This value suggests that none of the other variables
such as gender, antithrombotic treatment, GCS, size of
haematoma, paresis, aphasia, pupil difference, IVH and depth
of bleeding were statistically signiﬁcant. On the other hand,
removing any of the following three variables would be
signiﬁcant; age (p-value = 0.00002), mass effect (p-val-
ue = 0.038), and basal ganglia haemorrhage ( p-value = 0.040).
Likewise, the p-value from testing whether a model including
probability of good outcome (GOS > 3) versus all available
predictive variables differs from a model including probability
of good outcome versus age, basal ganglia haemorrhage, IVH,
and pupil difference equals 0.302. Therefore, none of the other
variableswere statistically signiﬁcant. However, removing any
of the following four variables would be signiﬁcant; age (p-
value = 0.00019), basal ganglia haemorrhage ( p-value = 0.006),
IVH (p-value = 0.037), and pupil difference (p-value = 0.099).
Age has the lowest p-value in both models, which suggests
a strong association of age with the probability of surviving or
having a good outcome. Basal ganglia haemorrhage has also a
very signiﬁcant associationwith good outcome. As an example
considering the effect of basal ganglia haemorrhage on GOS,the chance of surviving to an independent life for a 30 yrs. old
subject with basal ganglia haemorrhage and without IVH and
pupil difference is estimated to 2.46  107, whereas the
chance for a 30 yrs. old subject without basal ganglia
haemorrhage and IVH and pupil difference is estimated to
0.961.
The estimated coefﬁcients for age (0.1695), mass effect
(2.1791) and basal ganglia haemorrhage (1.64) in model-I are
positive. This point is illustrated in Fig. 1. The black line in this
ﬁgure shows the estimatedprobability ofmortality for patients
who have mass effect and basal ganglia haemorrhage at
different ages. The light green, dark green and blue lines
respectively show these estimations for the patients who do
not have basal ganglia haemorrhage but mass effect, do not
have mass effect but basal ganglia haemorrhage and ﬁnally
have neither. Clearly, the estimations for patients with both
basal ganglia haemorrhage and mass effect is higher.
Furthermore, the estimated probability of mortality for
patients increases with the age. On the other hand, the
estimated coefﬁcients for age (0.096), basal ganglia haemor-
rhage (18.44), IVH (1.53) and having pupil difference (1.19)
in model II are negative. The negative coefﬁcients suggest that
if all other variables are equal, the older peoplewho have basal
ganglia haemorrhage, IVH and pupil difference are less likely
to have an independent life, i.e. the estimated probability of
having good outcome decreases with the age of patients. This
point is illustrated in Fig. 2.
4. DiscussionIn order to facilitate decision-making and evaluate our
regional treatment efﬁcacy in sICH, we performed a retrospec-
tive study of morbidity and mortality in our surgically treated
patients. Our results after logistic multiple linear regression
[(Fig._1)TD$FIG]
Fig. 1 – The estimated mortality rate vs. age considering mass effect and basal ganglia haemorrhage.
[(Fig._2)TD$FIG]
Fig. 2 – The estimated probability of good outcome (GOS > 3) vs. age considering basal ganglia haemorrhage, IVH, and pupil
difference.
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n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 2 ( 2 0 1 8 ) 7 5 0 – 7 5 5754analysiswere comparable to international studies and showed
that despite surgical treatment, sICH is still a very serious
event, with a mortality rate of 18.3% and only 25.3% survival
chance for an independent life (GOS > 3). These numbers are
worryingly close to previous data and indicate that surgery
may improve the patients' chance of surviving sICH, but only
by increasing the number of patients who are care-dependent,
particularly considering patients over 65-years old. This is not
a surprising outcomebut this study actually is the ﬁrst study to
document that age is a factor to be considered in the decision-
making, when treating intracerebral hematomas in a neuro-
surgical unit.
Considering mortality rate, only age, basal ganglia hae-
morrhage andmass effect are signiﬁcant as variables. Age has
the lowest p-value suggesting a very strong association of age
with the probability of surviving. The positive coefﬁcient for
age, basal ganglia haemorrhage and mass effect suggests that
all other variables being equal, the older people, who have
mass effect and basal ganglia haemorrhage are less likely to
survive.
This study shows that older people who have basal ganglia
haemorrhage, IVH and pupil difference are less likely to have
an independent life after surgery. As shown in Fig. 2,
considering negative coefﬁcient between good outcome and
having IVH or pupil difference, especially when patients are
older or has basal ganglia haemorrhage, performing surgery
may beworthless or at least cannot provide a better prognosis.
According to the results, age and basal ganglia haemor-
rhage have strong effect both on mortality and on good
outcome, which means that performing surgery on older
patients with basal ganglia haemorrhage is almost without
survival chance (Figs. 1 and 2). Interestingly, bleeding in the
basal ganglia region is a strong predictor of having poor
outcome even in younger subjects without other variables.
As the study subjects had already been selected for
operation, Bias is conceivable in our study; however, the
study can be considered as an evaluation of the effect of the
current surgical inclusion criteria in our region,which is in line
with the STICH studies. Furthermore, in the STICH studies,
initially randomized patients for conservative management,
could also undergo surgery depending on the clinically
judgement of the attendant physician [9], which is almost
like the policy of our department.
In brief, the STICH study concluded that there was no
general advantage of surgery, but that a slight beneﬁt from
surgery was probable if the haematoma was less than 1 cm
from the cerebral surface on conscious patients. STICH II went
on to look more closely at this subgroup of patients, only
including conscious patients with smaller haematomas less
than 1 cm from cerebral surface. Considering inclusion
criteria, STICH II showed that the number of patients eligible
for recruitment is low, indicating that an aggressive recruit-
ment approach for surgerymay be beneﬁcial [10]. Results were
once again sparse, but the authors ended up concluding that
this subgroup (of the subgroup) would beneﬁt from surgical
treatment. The conclusions of these twomajor studies are still
debated. Similarly, there are some shortcomings in the STICH
studies such as the surgical approach, whichwasmostly (77%)
craniotomy. For this reason, conclusions cannot be made on
the effect of other surgical approaches. Furthermore, themedian time from onset to surgery was relatively long (about
30 h), so the beneﬁts of surgery e.g. within 12 h remain
unresolved [9]. Some studies have shown that there is no
difference between patients receiving an early haematoma
evacuation (8 h between onset and surgery) and conservative
treatment, however the number of subjects in the study was
very low [11].
Moreover, the survival advantage in STICH studies appears
to be greatest when the prognosis is poorer (Glasgow Coma
Score 9–12), and when patients are randomly assigned to
surgery within 21 h [5], which means the effect of GCS on the
result of surgery is probably affected by the judgement of the
surgeons. Although our study does not show a strong
correlation between GCS and good clinical outcome, it is
maybe more careful to describe a potential trend towards a
correlation.
Our retrospective study did not let us to choose the time of
surgery or surgical technique, which was mostly craniotomy,
like STICH studies, but it seems relevant to design some
studies in the future with other methods, and deﬁnitely with a
shorter period between bleeding onset and surgery.
Acknowledgement and ﬁnancial supportWe would like to express our special thanks to MSc. Michael
Kjærgaard Sørensen for statistical analysis, Ass. Prof. Dariusz
Orlowski and MA Anne Soﬁe Møller Anderson for help in
manuscripts editing, and Ms. Anja Kobberø for collecting of
medical journals.
Clinical implicationsBased on our results, it is our opinion that the surgery of sICH
should be reserved for conscious patients with a favourable
prognosis, who deteriorate after a period of observation, and
that surgery only has a role in treating sICH if patients are
carefully selected, by taking haematoma characteristics and
patient age into consideration in order to improve outcome.
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